Citation Impact
Citing Papers
Comparison of Two Fluid-Management Strategies in Acute Lung Injury
2006 Standout
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Constitutive Expression of IDO by Dendritic Cells of Mesenteric Lymph Nodes: Functional Involvement of the CTLA-4/B7 and CCL22/CCR4 Interactions
2009 StandoutNobel
Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
2010
Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation
2015 StandoutNobel
Judging quality of current septic shock definitions and criteria
2015
Re-establishing immunological self-tolerance in autoimmune disease
2012 StandoutNobel
Critical Care in the Emergency Department A Physiologic Assessment and Outcome Evaluation
2000
CTLA4Ig: Bridging the Basic Immunology with Clinical Application
2006
An evaluation of the end points of resuscitation11The opinions and assertions contained herein are the private views of the author and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense. This article is based on a review first reported in the Journal of the US Army Medical Department 1997; PB 8-97-11/12:30-34.
1998
The Rheumatoid Arthritis Drug Development Model: a case study in Bayesian clinical trial simulation
2009
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
2010
Pathogenetic Mechanisms of Septic Shock
1993 Standout
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
2001 Standout
Occult hypoperfusion is associated with increased mortality in hemodynamically stable, high-risk, surgical patients
2004
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
2012 StandoutNobel
New therapies for treatment of rheumatoid arthritis
2007
Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease‐modifying antirheumatic drugs: A one‐year randomized, placebo‐controlled study
2006
Rheumatoid arthritis
2016 Standout
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
2005
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
The B7 family of immune-regulatory ligands.
2005
Essential role of microRNA‐155 in the pathogenesis of autoimmune arthritis in mice
2011
Even though T-cell-directed trials have been of limited success, is there reason for optimism?
2006
Neutrophils in development of multiple organ failure in sepsis
2006
Frequency of mortality and myocardial infarction during maximizing oxygen delivery
1995
Juvenile idiopathic arthritis
2007 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
A Randomized, Controlled Trial of the Use of Pulmonary-Artery Catheters in High-Risk Surgical Patients
2003 Standout
T cell epitope–specific immune therapy for rheumatic diseases
2005
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4
2005 StandoutNobel
Co‐stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
2005 StandoutNobel
The changing landscape of atherosclerosis
2021 StandoutNature
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
2009
Elevation of Cardiac Output and Oxygen Delivery Improves Outcome in Septic Shock
1992
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
2008
Severe Sepsis and Septic Shock
2013 Standout
Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial
2006
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Current Understanding of Sepsis
1996
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Resuscitation of the critically III in the ED: Responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate
1996
How antirheumatic drugs protect joints from damage in rheumatoid arthritis
2008
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Abatacept
2006
Normal-Range Blood Lactate Concentration in Septic Shock Is Prognostic and Predictive
2012
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve‐month results of a phase iib, double‐blind, randomized, placebo‐controlled trial
2005
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
2006 StandoutNobel
Serial blood lactate levels can predict the development of multiple organ failure following septic shock
1996
Graves' Ophthalmopathy
2010 Standout
Has the mortality of septic shock changed with time?
1998
Sepsis and septic shock
2018 Standout
The B7/CD28 costimulatory family in autoimmunity
2005
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study
2009
Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
2008
Hydrocortisone Therapy for Patients with Septic Shock
2008 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial
2007
Results of a two‐year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
2008
Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity
2004
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Abatacept therapy and safety management
2009
Cancer immunotherapy comes of age
2011 StandoutNature
Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways
2008
Rheumatoid arthritis
2010 Standout
Clinical Trials of Transplant Tolerance: Slow But Steady Progress
2003
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
2009
Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review
2010
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
2014
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Hemodynamic Effects of IV Milrinone Lactate in Pediatric Patients With Septic Shock
1996
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
2009 Standout
Cardiovascular management of septic shock
2003
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Early lactate clearance is associated with improved outcome in severe sepsis and septic shock*
2004 Standout
Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood
1999
The Epidemiology of Sepsis in the United States from 1979 through 2000
2003 Standout
Lactate Measurements in Sepsis-Induced Tissue Hypoperfusion
2014
Rheumatoid Arthritis
2008
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Biologics in development for rheumatoid arthritis: Relevance to osteoarthritis☆
2006
Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40
2004
Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update
2004
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
Adalimumab in the Treatment of Rheumatoid Arthritis
2006
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Methotrexate in Rheumatoid Arthritis
1987
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
Effector and Memory CTL Differentiation
2006
Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality
1999 Standout
Hemodynamic Support in Fluid-refractory Pediatric Septic Shock
1998
Adaptive Response of T and B Cells in Atherosclerosis
2016
Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges
2005
Description of the Efficacy and Safety of Three New Biologics in the Treatment of Rheumatoid Arthritis
2010
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis
2006
The Use and Clinical Importance of a Substrate-Specific Electrode for Rapid Determination of Blood Lactate Concentrations
1994
Clinical review: Circulatory shock - an update: a tribute to Professor Max Harry Weil
2012
Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs
2014
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock
1996
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
2016 Standout
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
2011 StandoutNobel
Part 14: Pediatric Advanced Life Support
2010 Standout
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
2015 StandoutNobel
Generic quality-of-life assessment in rheumatoid arthritis.
2007
Works of Marc Léon being referenced
Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig
2003
Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose‐finding, double‐blind, placebo‐controlled clinical trial evaluating CTLA‐4Ig and LEA29Y eighty‐five days after the first infusion
2002
Blood Lactate Levels Are Superior to Oxygen-Derived Variables in Predicting Outcome in Human Septic Shock
1991
Veno-arterial Carbon Dioxide Gradient in Human Septic Shock
1992
Myocardial depression characterizes the fatal course of septic shock.
1992